1837P Febrile neutropenia (FN) primary prophylaxis (1º Prlx) with platinum and etoposide (P&E) chemotherapy (ChT) regimens: Some action needed von Spencer, A.S., Palma dos Reis, A.F., Parmanande, A., Barreira, J.V., Simão, D., Sardinha, M., Mendes, J., Machado, A., Pereira, P.W., Luz, R.

Volltext

Development and evaluation of a real-world data-based prognostic score in castration-resistant metastatic prostate cancer von Gramaça, J., Palma Dos Reis, A.F., Gameiro Dos Santos, R., Fernandes, I., Trabulo, C., Baptista, A., Da Luz, R., Pina, I.

Volltext

Checkpoint inhibitor immune-related adverse events as a prognosis factor in urothelial cancer: A retrospective analysis von Parmanande, A.Q., Barreira, J.V., Spencer, A.S., Simão, D.C., Palma Dos Reis, A.F., Sardinha, M., Luz, R.

Volltext

P155 - Checkpoint inhibitor immune-related adverse events as a prognosis factor in urothelial cancer: A retrospective analysis von Parmanande, A.Q., Barreira, J.V., Spencer, A.S., Simão, D.C., Palma Dos Reis, A.F., Sardinha, M., Luz, R.

Volltext